Literature DB >> 1567686

Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue.

K J Walker1, R A McClelland, W Candlish, R W Blamey, R I Nicholson.   

Abstract

The heterogeneity of oestrogen receptor (ER) expression has been examined in both normal and malignant breast tissue using an immunohistochemical assay. In both instances the ER status and cellular ER negativity were influenced by the patients' menopausal status, with tissues removed from premenopausal women being more often ER-negative, and when ER-positive, containing a high proportion of apparently ER-negative cells. Since the breast is normally regarded as hormone sensitive and since tumour cell ER negativity is apparently under a degree of hormonal regulation, our results suggest that the proportion of breast cancer cells that are ER-negative should be viewed with a degree of caution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567686     DOI: 10.1016/0959-8049(92)90379-g

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

2.  Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo.

Authors:  P Rostagno; J L Moll; I Birtwisle-Peyrottes; F Ettore; C Caldani
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

4.  4-Hydroxytamoxifen differentially exerts estrogenic and antiestrogenic effects on discrete subpopulations of human breast cancer cells.

Authors:  S T Willard; E J Abrahman; W J Faught; D C Leaumont; L S Frawley
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

5.  Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens.

Authors:  P Rostagno; C Caldani; B Lahlou
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Are the estrogen receptor and SIRT3 axes of the mitochondrial UPR key regulators of breast cancer sub-type determination according to age?

Authors:  Edmund Charles Jenkins; Mrittika Chattopadhyay; Doris Germain
Journal:  Aging Cancer       Date:  2021-08-06

7.  Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes.

Authors:  R A McClelland; D L Manning; J M Gee; E Anderson; R Clarke; A Howell; M Dowsett; J F Robertson; R W Blamey; A E Wakeling; R I Nicholson
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

Authors:  R I Nicholson; R A McClelland; J M Gee; D L Manning; P Cannon; J F Robertson; I O Ellis; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 9.  Oestrogen receptor: a stable phenotype in breast cancer.

Authors:  J F Robertson
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

Review 10.  Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Authors:  R I Nicholson; J M Gee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.